Announcing a new publication for Acta Materia Medica journal. Bioresponsive materials have gained prominence as innovative ...

Fully cell-free process aims to democratize personalized cancer therapeutics with shorter turnaround and negligible bioburden ...

VYNE Therapeutics Inc. (NASDAQ:VYNE) is among the fundamentally strong penny stocks to invest in. Analysts at H.C. Wainwright ...

FDA designates FF-10832 as an orphan drug for biliary tract cancer, promising enhanced treatment options for this aggressive ...

HBO is a network built on quality content. The following series are no exception to that rule, but each deserves a larger audience.

Recent developments in protein-protein interactions (PPI) give hope for patients with advanced or untreatable diseases.

In parallel, e-therapeutics has successfully completed GMP manufacturing of the clinical batch of ETX-312, supporting the Company’s operational readiness to progress to first-in-human dosing.

Panelists discuss how exciting ongoing research efforts are expanding similar gene therapy technologies to other muscular ...

Cybin has made steady progress but faces major hurdles, with its stock swayed by sector sentiment. Read why CYBN stock is ...

Using newly developed mouse models and a microglia replacement strategy, researchers show that bone marrow transplantation could be used as an ...

Antimicrobial resistance not only undermines the efficacy of current treatments but also endangers the entirety of modern ...

Digital technology may be on the verge of ‘breaking out’ for schizophrenia treatment, but numerous questions will need to be ...